2024 annual financial data
BioNTech 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was 7.55%.
Operating income was -1,314,300,000 EUR and net income was -665,300,000 EUR.
Operating cash flow was 207,700,000 EUR.
Get free BioNTech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,751,100,000 EUR
- Operating income
- -1,314,300,000 EUR
- Net income
- -665,300,000 EUR
- Operating cash flow
- 207,700,000 EUR